Literature DB >> 19784742

The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems.

Yasuto Kunii1, Shin-ichi Niwa, Yoshiaki Hagiwara, Masahiro Maeda, Tsutomu Seitoh, Toshimitsu Suzuki.   

Abstract

To elucidate the cellular distribution of osteopontin (OPN) in normal human tissues, we undertook immunohistochemistry using two site-specific OPN antibodies. The 10A16 monoclonal antibody was raised against the amino acid sequence just downstream of the thrombin cleavage site, while the O-17 polyclonal antibody was raised against the N-terminal peptide. Each antibody has been confirmed previously to react with both whole OPN and its relevant fragments. The expression pattern for these two antibodies was similar in distribution. In addition, we also identified expression in Ebner's gland, type II pneumocytes, Kupffer cells, cells of the endocrine organs, anterior lens capsule and ciliary body, synovial type A cells, mesothelia, adipocytes, and mast cells. Neurons and glia in the central nervous system and spinal cord, cranial and peripheral nerve sheaths, ganglion cells in the sympathetic ganglion, intestinal plexuses, retina, and choroid plexus also regularly exhibited OPN positivity. Testicular germ cells, pancreatic exocrine cells, and follicular dendritic cells reacted with 10A16 only, whereas lutein cells and taste bud cells exhibited O-17 reactivity alone. These minor differences were hypothesized to reflect the state of OPN in the cells; that is, whether OPN was in its whole molecule or fragmented form. In conclusion, we demonstrate that OPN is widely distributed in normal human cells, particularly those comprising the central and peripheral nervous systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784742     DOI: 10.1007/s00795-009-0459-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  49 in total

1.  SIBLING expression patterns in duct epithelia reflect the degree of metabolic activity.

Authors:  Kalu U E Ogbureke; Larry W Fisher
Journal:  J Histochem Cytochem       Date:  2007-01-08       Impact factor: 2.479

2.  Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus.

Authors:  A Fierabracci; P A Biro; Y Yiangou; C Mennuni; A Luzzago; J Ludvigsson; R Cortese; G F Bottazzo
Journal:  Vaccine       Date:  1999-09       Impact factor: 3.641

3.  Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose.

Authors:  C P Sodhi; S A Phadke; D Batlle; A Sahai
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

4.  Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas.

Authors:  R Kawashima; S Mochida; A Matsui; Y YouLuTuZ; K Ishikawa; K Toshima; F Yamanobe; M Inao; H Ikeda; A Ohno; S Nagoshi; T Uede; K Fujiwara
Journal:  Biochem Biophys Res Commun       Date:  1999-03-24       Impact factor: 3.575

Review 5.  Osteopontin: role in cell signaling and cancer progression.

Authors:  Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal:  Trends Cell Biol       Date:  2006-01-10       Impact factor: 20.808

Review 6.  Expression, roles, receptors, and regulation of osteopontin in the kidney.

Authors:  Y Xie; M Sakatsume; S Nishi; I Narita; M Arakawa; F Gejyo
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

7.  Osteopontin expression in chronic pancreatitis.

Authors:  Mitsuo Nakamura; Masaaki Oka; Norio Iizuka; Shigeto Kawauchi; Toshikazu Gondo; Tomio Ueno; Akira Tangoku
Journal:  Pancreas       Date:  2002-08       Impact factor: 3.327

8.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

Review 9.  Osteopontin: roles in implantation and placentation.

Authors:  Greg A Johnson; Robert C Burghardt; Fuller W Bazer; Thomas E Spencer
Journal:  Biol Reprod       Date:  2003-07-30       Impact factor: 4.285

10.  Osteopontin is up-regulated in human decidual stromal cells.

Authors:  Michael von Wolff; Michael K Bohlmann; Christiane Fiedler; Stefanie Ursel; Thomas Strowitzki
Journal:  Fertil Steril       Date:  2004-03       Impact factor: 7.329

View more
  11 in total

1.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

Review 2.  Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.

Authors:  Thomas E Kruger; Andrew H Miller; Andrew K Godwin; Jinxi Wang
Journal:  Crit Rev Oncol Hematol       Date:  2013-09-07       Impact factor: 6.312

3.  Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals.

Authors:  Amanda Brown; Tanzeem Islam; Robert Adams; Sujata Nerle; Masiray Kamara; Caitlin Eger; Karen Marder; Bruce Cohen; Giovanni Schifitto; Justin C McArthur; Ned Sacktor; Carlos A Pardo
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

4.  Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment.

Authors:  Serena E O'Neil; Carina Malmhäll; Konstantinos Samitas; Teet Pullerits; Apostolos Bossios; Jan Lötvall
Journal:  Allergy Asthma Clin Immunol       Date:  2010-11-02       Impact factor: 3.406

5.  Osteopontin and fibronectin levels are decreased in vitreous of autoimmune uveitis and retinal expression of both proteins indicates ECM re-modeling.

Authors:  Cornelia A Deeg; Christina Eberhardt; Florian Hofmaier; Barbara Amann; Stefanie M Hauck
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

6.  (1)H, (15)N, (13)C resonance assignment of human osteopontin.

Authors:  Gerald Platzer; Szymon Żerko; Saurabh Saxena; Wiktor Koźmiński; Robert Konrat
Journal:  Biomol NMR Assign       Date:  2015-01-24       Impact factor: 0.746

7.  Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.

Authors:  Qiu Yushi; Zhimin Li; Christina A Von Roemeling; Heike Doeppler; Laura A Marlow; Betty Y S Kim; Derek C Radisky; Peter Storz; John A Copland; Han W Tun
Journal:  Oncotarget       Date:  2016-05-31

8.  Secreted Phosphoprotein 1 Expression in Retinal Mononuclear Phagocytes Links Murine to Human Choroidal Neovascularization.

Authors:  Anja Schlecht; Peipei Zhang; Julian Wolf; Adrian Thien; Dennis-Dominik Rosmus; Stefaniya Boneva; Günther Schlunck; Clemens Lange; Peter Wieghofer
Journal:  Front Cell Dev Biol       Date:  2021-01-28

9.  Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells.

Authors:  S Saleh; D E Thompson; J McConkey; P Murray; R A Moorehead
Journal:  BMC Cancer       Date:  2016-06-10       Impact factor: 4.430

Review 10.  Osteopontin at the Crossroads of Inflammation and Tumor Progression.

Authors:  Luigi Mario Castello; Davide Raineri; Livia Salmi; Nausicaa Clemente; Rosanna Vaschetto; Marco Quaglia; Massimiliano Garzaro; Sergio Gentilli; Paolo Navalesi; Vincenzo Cantaluppi; Umberto Dianzani; Anna Aspesi; Annalisa Chiocchetti
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.